After Hours Summary: Quiet after hours; QDEL -1.1% ticks lower despite upside guidance; PCRX -2.3% down after hoursAfter Hours Gainers:
Companies trading higher in after hours in reaction to news: OTIC +19.5% (provides update on OTIVIDEX program, reports "positive" top-line results from Phase 1/2 trial), GLDD +10.2% (wins several dredging awards totaling $51.1 mln), B +6.7% (announces restructuring actions, including workforce reductions), UBX +3.7% (announces departure of CFO Bob Goeltz), CATS +0.5% (to change its name and ticker to Ontrak (OTRK))
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: QDEL -1.1% (guides Q2 revs above consensus)
Companies trading lower in after hours in reaction to news: CLLS -15.7% (announces clinical hold for MELANI-01 trial), CIDM -6.7% (files for $75 mln mixed securities shelf offering), RVMD -4% (announces offering of 5.5 mln shares), PING -3.9% (guides Q2 revs above consensus, but co says some customers phased-in their purchases, resulting in smaller deal sizes; also files for 7.5 mln share offering by selling shareholders), PCRX -2.3% (guides Q2 revs well above consensus; also announces $300 mln convertible offering), ARE -1.9% (commences 5 mln share offering)
Gapping down
M&A news:
- D -1.4% (Dominion Energy's Gas Transmission and Storage Business acquired by Berkshire Hathaway)
Other news:
- BLU -76.4% (announced topline results from its Phase 2 RELIEF trial of BLU-5937 in patients with refractory chronic cough)
- OBSV -6.2% (reports results from two Phase 3 studies, PRIMROSE 1 and 2, of Yselty)
- APLT -5.6% (continued pressure following short report)
- VIR -3% (announces proposed underwritten public offering of 6,200,000 shares of its common stock)
- VXX -2.9% (trading lower with US futures up over 1%)
- UIHC -1.9% (provides estimates of Q2 catastrophe losses)
- ETNB -1.8% (commences underwritten public offering of 2,200,000 shares of common stock)
- AKRO -0.8% (files for 4.75 mln share common stock offering)
Analyst comments:
- SPOT -1.5% (downgraded to Underperform from Mkt Perform at Bernstein)
- GMED -1.4% (downgraded to Neutral from Overweight at Piper Sandler)
- EVH -0.7% (downgraded to Sector Weight from Overweight at KeyBanc Capital Markets)
- INTC -0.5% (downgraded to Sell from Neutral at Goldman)